Archive | Innovator’s Pitch Challenge RSS feed for this section

Digital RESI JPM Pitch Applications Open

18 Nov

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

Today is the last day of the Digital RESI November Innovator’s Pitch Challenge. If you missed your opportunity to pitch to relevant investors seeking opportunities in your space, Digital RESI JPM, January 11-13, 2022 is right around the corner! Join us at the biggest virtual fundraising event of the year and submit your application the the Digital RESI JPM Innovator’s Pitch Challenge.

What is it?

The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. Participating companies pay registration and a $800 pitching fee to host their company materials on the Live Agenda and participate in the live pitch session.

How Does it Work?

Pitching companies will have a dedicated webpage on the Live Agenda, which greatly increases visibility to investors. Prior to the live pitch session, the investor panel will review submitted pitch materials and prepare questions.

Each company has approximately 10 minutes set aside for their participation. Each session is judged by a panel of investors who have expressed interest in the sector(s) highlighted in the session. During the session, the pitching company delivers a brief (~1 minute) elevator pitch, and saves the rest of their time for investors’ questions, feedback and commentary. The session is open to all registered RESI attendees.

IPC-EXAMPLE-Page

Who Should Apply?

Early-stage life science companies actively raising seed capital (25K-2MM), Series A (2MM-10MM), or Series B (10MM-50MM) use the IPC to get in front of the panel of qualified investor judges in their market segment and pitch their company and product. Early-stage companies are encouraged to submit an application, along with a pitch deck and an executive summary. Once selected to pitch, companies can submit their video and supplemental materials for investors to review prior to the live session.

Apply for IPC with Icon

Digital RESI November at a Glance

18 Nov

By Karen Deyo, Director of Investor Research, Israel BD, LSN

Digital RESI November is not over yet but has so far been one of our most successful virtual events. With over 600 attendees from 30 countries across 5 continents, RESI continues to demonstrate how truly global Life Science Nation (LSN)’s early-stage ecosystem is. Attendees have had access to investor panels, workshops and could watch over 50 presenting companies in the Innovator’s Pitch Challenge. With two days down and one day left, over 1,000 meetings have already taken place through RESI’s unique, match-based partnering platform. With our next RESI, taking place during JP Morgan Healthcare Week, right around the corner, make sure not to miss out on the next opportunity to take part in a virtual event that truly works! Sign up by November 28 to save $300!


Innovator’s Pitch Challenge – Finalists Announced!

4 Nov

By Gregory Mannix, Vice President International Business Development, General Manager Europe, LSN

At Digital RESI November we will again be showcasing top technologies across Drugs, Devices, Diagnostics and Digital Health in this edition of the Innovator’s Pitch Challenge. These companies will be featured on the RESI Live Agenda and will participate in live Pitch Sessions focused on a particular sector or indication, fielding questions from a panel of selected investors and industry experts.  The IPC has grown tremendously in popularity over the past year and attracts a big virtual audience, including investors and strategic partners.

Best of luck to the finalists!!

RESI-NOV-Banner-3050x-1050

Applications Due Tomorrow

28 Oct

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

The Innovator’s Pitch Challenge (IPC) is a highlight at Life Science Nation events, with innovative startups in life science and healthcare pitching to investors in a live Q&A format, providing feedback, practice, and for some, valuable connections that lead to deals. The IPC returns to Digital RESI November 16-18 and there is one day left to apply at the extended deadline!

If you are involved with a company in active fundraising mode and want to boost your exposure, gain valuable feedback from investors and industry experts, and secure meetings with investors who have a genuine interest in your technology, you do not want to miss out on the last IPC of 2021!

Below is a list of companies who have been accepted as finalists – conference attendees will be able to vote for their favorite pitch.

 

RESI-NOV-Banner-3050x-1050

Innovator’s Pitch Challenge Applications Due Tomorrow

21 Oct

By Megan Rychwa, Investor Research Analyst, LSN

Life Science Nation’s last conference of the year, Digital RESI November 16-18, is currently accepting applications from startup companies across the globe for the popular Innovator’s Pitch Challenge (IPC). The number of participating startups has doubled within the last year, with hundreds of companies and investors experiencing the value firsthand. Applications are accepted on a rolling basis until Friday, October 22.

The Innovator’s Pitch Challenge is an opportunity for early-stage companies to pitch to a live panel of investors within their sector. Each company’s marketing materials are highlighted on their dedicated webpage, as well as their recorded pitch, which investors can see prior to the conference in preparation for the live event. The pitch session is a unique chance for companies to gain exposure to a large investor audience and prepare those companies to build strategic partnerships with well-matched investors. The cost for IPC finalists includes event registration, as well as a $500 pitch fee.

The deadline for IPC applications is tomorrow, so make sure your application is in and you don’t miss out on this great opportunity to tell your story!

RESI-NOV-Banner-3050x-1050

Come for the Pitch, Stay for the Relationship

14 Oct

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

Bright-eyed entrepreneurs with big ideas and even bigger fundraising needs have joined Digital RESI throughout 2021 in hopes of meeting investors who are just as excited to meet them, and there’s no virtual meeting spot that brings the two together like the Innovator’s Pitch Challenge (IPC). Apply to pitch at DIgital RESI November by October 22!

The IPC provides opportunities for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. Fundraising entrepreneurs use the IPC for exposure, connection, valuable feedback, and often, a conversation that leads to many more down the road. Investors use it for the same – the opportunity to hear from and connect with entrepreneurs, learn more about exciting technology, and advance deal-flow initiatives.

For these reasons, the IPC is one of the most popular and well-attended features of the Digital RESI conference series, but don’t take our word for it. See what investors have said about their participation and check out previous investors that have sat on IPC judging panels throughout 2021.

“It was a very economical use of time; the investors got to ask their important questions and the Innovators got a good idea of the most pressing questions from the investors point of view.”
William Kuziel, MedPro Investors
“The Pitch Sessions are a great opportunity to connect with startup CEOs and learn more about their work…It really has been an effective and efficient way to make connections, create deal flow and help startups raise money for their upcoming raises.”
Mayank Taneja, OSF Healthcare
“I look forward to LSN’s events because they provide an opportunity for our venture capital firm to find promising companies with exceptional technologies. The organization and technology platform make it very easy to hear numerous pitches from founders.”
Nat Brinn, VC23
“The Pitch Sessions were a great opportunity to engage with the CEO/Founders of very innovative Life Science startups. Despite the COVID-related transition from in-person to virtual meetings, the RESI team did an outstanding job organizing these sessions, ensuring that the live Q&A was very productive, and facilitating follow-up with these exciting companies.”
Gary Gershony, Life Science Angels / BayMed Venture Partners
Previous 2021 Investor Judges
Hamzeh Abdul-Hadi
Hikma Ventures
Aiden Aceves
Vida Ventures
Nuno Afonso
Apogee Ventures
Brent Ahrens
Canaan Partners
Alexandra Amen
BridgeBio
Richard Anders
Mass Medical Angels
Bauke Anninga
M Ventures
Marc Appel
Orange Grove Bio
Anjan Aralihalli
CTI Life Sciences Fund
Aimee Barkway
Hadean Ventures
Amine Benmoussa
Apogee Ventures
Attila Berces
FastVentures
Sascha Berger
TVM Capital Life Science
Randy Berholtz
Mesa Verde Venture Partners
Reetika Bhardwaj
ARCH Venture Partners
Ivneet Bhullar
Fusion Fund
Yoann Bonnamour
Mérieux Equity Partners
Todd Brady
Brace Pharma Capital
Nat Brinn
VC23
Ivan Burkov
INKEF Capital
Cynthia Cai
Viva BioInnovator
Valerie Calenda
Mérieux Equity Partners
Anke Cassing
High-Tech Gründerfonds
Jeremy Chang
BridgeBio
Benjamin Chen
Panacea Ventures
Kenneth Chew
Vickers Venture Partners
Poh Hui Chia
Vickers Venture Partners
Chinmay Chinmay
BioIdeations
Elizabeth Cho-Fertikh
Meda Angels
Michel Chu
Acorn Campus Taiwan
Pablo Cironi
Caixa Capital Risc
Barbara Clarke
Astia Angels
Darren Cooke
Life Science Angels
Peter Crane
Outsized Ventures
David Crean
Mesa Verde Venture Partners
Ruchi Dana
Dana Group
Aldemar Degroot
Biogen
Niels Emmerich
AbbVie Inc.
Bettina Ernst
BERNINA BioInvest
Jemima Escamilla
Research Corporation Technologies
Naomi Fried
Ambit Health Ventures
Ryo Fujinami
Shinsei Capital Partners
Robert Garber
7wire Ventures
Gary Gershony
BayMed Venture Partners
Tom Gibbs
Debiopharm Innovation Fund
Sam Goldberger
Ambit Health Ventures
Gage Greening
Medical Technology Enterprise Consortium (MTEC)
Bryan Grulke
Volcano Capital
Brian Hakim
MedtecX
Elaine Hamm
Ascend BioVentures
Z Haroon
Julz Co LLC
Christopher Haskell, Ph.D.
Bayer
Michelle Ho
5AM Ventures
Vivien Ho
Pear Ventures
Alan Hochberg
Roche
Dave Hood
Medical Technology Enterprise Consortium (MTEC)
Dmitrij Hristodorov
Forbion Capital Partners
Adam Hunke
Banner Venture Group
Tomoko Ishikura
Kicker Ventures
Mishael Zohar
OrbiMed Advisors LLC
I-Chien Jan
Hukui Bio
Allan Johnston
Synergy Ventures
Rick Jones
BioAdvance
Patrick Keenan
Prevail Partners
Faisal Khan
AstraZeneca
John Kim
Aphelion Capital, LLC
Kristin King
Boston Harbor Angels
Merom Klein
Keiretsu Forum
Pascal Krotee
RiverVest Venture Partners
Dmitry Kuzmin
4Bio Capital Partners
Sebastien Latapie
Dynamk Capital
Zachary Leach
Catalyst Health Ventures
Carla Lema Tomé
Otsuka Pharmaceutical
Elliot Levy
DreamIt Health
George Li
Proxima Ventures
Yatong Li
Sixty Degree Capital
Xinhong Lim
Vickers Venture Partners
Debbie Lin
Boehringer Ingelheim Venture Fund
Don Lin
Guoqian Venture Capital Investment
Henry Lu
China Merchants Capital
Benedikt Luhmann
VI Partners
Marc Martin-Casas
Illumina Accelerator
Tai Mei
Meda Angels
Andy Merken
Burns & Levinson
Wouter Meuleman
Illumina Ventures
Junaid Mian
SP8CEVC
Sergio Montero
Start-Up Chile
Walter Moos
Pandect Bioventures
Anesa Mulabecirovic
Hadean Ventures
Kim Nearing
BVCF
Justin Norden
GSR Ventures
Cédric Odje
Debiopharm Innovation Fund
Michael O’Donnell
Life Science Angels
Marion Paolini
Servier
Nami Park
Life Science Angels
Francoise Perron-Sierra
Servier
Dave Pinkowitz
AnPac Bio
Rohit Pratap Singh
Xeraya Capital
Mark Ralph
Boehringer Ingelheim Venture Fund
Varun Ramdevan
Johnson & Johnson Innovation
iGan Partners Employees, Location, Careers | LinkedIn
David Ramos
iGan Partners
Richard Reschen
MSD
Stella Robertson
Bios Partners
Mel Rothberg
Mira Life Science Ventures
Nikhil Sadhwani
Individual Angel
Caroline Sai
Angels Santé
Christina Salys
Intuitive Surgical
Diana Saraceni
Panakes Partners
Barbara Schilberg
BioAdvance
Steve Seuntjens
Personal Health Solutions
Bryan Shao
Keiretsu Forum
Niels Sharman
High-Tech Gründerfonds
Megan Shaw
Innovation Works
David Siet
Amzak Health
Mira Sirotic
Keiretsu Forum
Catello Somma
TVM Capital Life Science
Jill Sorensen
Medical Technology Enterprise Consortium (MTEC)
Adarsh Sowcar
NOVA
Karen Spilizewski
RiverVest Venture Partners
Mark Springel
Vida Ventures
Sanjay Srinivasan
Accent Advisors
Eran Steinberg
Imaging Arts
Kevin Sterling
Keiretsu Forum
Weiyong Sun
Daiichi Sankyo
Ben Sun
Sand Hill Angels
Haolin Sung
Chaperone Investment
Gayathri Swaminath
GreenFire Bio, LLC
Mayank Taneja
OSF Healthcare Ventures
Mark Tang
Good Health Capital
Liz Todia
Mutual Capital Partners
Gadi Toren
Robert Bosch Venture Capital
Bill Trainor
Mutual Capital Partners
Robert Tucci
Texas Halo Fund
Thomas Vogelsong
KYTO Technology and Life Science
Tad Weems
Agilent Technologies
Scott Weiner
Amzak Health
Travis Whitfill
Bios Partners
Thierry Wurch
Ipsen S.A.
Jonathan Yeh
Saisei Ventures
John Yianni
Earlybird
Alicia Yin
6 Dimensions Capital
Derek Yuan
LYFE Capital
Yanxiang Zhou
Illumina Ventures
Anthony Zlaket
UnityPoint Health Ventures

RESI-NOV-Banner-3050x-1050

Stories from the Innovator’s Pitch Challenge

30 Sep

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

Since going digital in 2020, RESI conferences have been able to grow and meet the unique needs of virtual partnering in many ways, but few more exciting than the Innovator’s Pitch Challenge (IPC). The IPC is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. Participating companies pay registration and a $500 pitching fee to host their company materials on the Live Agenda and participate in the live pitch session.

Applications are due October 22, but those who apply by October 8 save an additional $200 with super early bird registration rates. Hear from past participants about their experiences pitching at RESI conferences and how their experiences contributed to their global fundraising efforts.

RESI-NOV-Banner-3050x-1050

%d bloggers like this: